Sage Therapeutics Inc Equity-NMS: SAGE

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$41.98

52W high :

$47.75

1Y :

1.09%

5Y :

-49.28%

EPS(TTM): :

-8.53

Shares O/S :

59.42 M

Market cap :

2.55 B

What is the share price of Sage Therapeutics Inc today?

Sage Therapeutics Inc (SAGE) share price as of August 12, 2022, is $42.99. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Sage Therapeutics Inc?

Yes, Indian Investors can invest in the Sage Therapeutics Inc (SAGE) Share by opening an international trading account with Angel One.

How can I purchase Sage Therapeutics Inc shares in India?

Purchasing Sage Therapeutics Inc (SAGE) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Sage Therapeutics Inc (SAGE) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Sage Therapeutics Inc?

Yes, you can purchase fractional shares of Sage Therapeutics Inc (SAGE) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Sage Therapeutics Inc?

The market capitalization of Sage Therapeutics Inc on August 14, 2022, is $2.55 B.

In which sector Sage Therapeutics Inc belongs?

Sage Therapeutics Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Sage Therapeutics Inc stocks?

In order to invest in Sage Therapeutics Inc (SAGE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Sage Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing medicines with debilitating disorders of the brain. The Company's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD) in adults. It has a portfolio of other product candidates with a focus on modulating two central nervous system (CNS) receptor systems, GABA and NMDA. It targets diseases and disorders of the brain with three focus areas: depression, neurology and neuropsychiatry. Its other advanced product candidate is zuranolone (SAGE-217), an oral compound being developed for certain affective disorders, including major depressive disorder (MDD) and PPD. Zuranolone is a neuroactive steroid that is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors. It has a portfolio of other compounds that target GABAA receptors, including SAGE-324.